NMDA receptor function in large-scale anticorrelated neural systems with implications for cognition and schizophrenia
Alan Anticevic, Mark G. Gancsos, John D. Murray, Grega Repovš, Naomi R. Driesen, Debra J. Ennis, Mark J. Niciu, Peter T Morgan, Toral Surti, Michael H. Bloch, Ramachandran Ramani, Mark A. Smith, Xiao-Jing Wang, John H. Krystal, Philip R. Corlett
Proceedings of the National Academy of Sciences September 25, 2012 DOI: 10.1073/pnas.1208494109 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Experimental study Peer reviewed |
|---|---|
| Population | Humans |
| Intervention | Ketamine |
| Keywords | Nmda receptor Disinhibition Schizophrenia object-oriented programming Cognition Glutamatergic Glutamate receptor Ampa receptor Memantine |
| Citations | 260 |
| Key findings | Ketamine administration disrupted the anticorrelated relationship between default-mode and task-positive brain systems, and this disruption predicted task performance and transient schizophrenia-like symptoms. |
Abstract
Glutamatergic neurotransmission mediated by N-methyl-d-aspartate (NMDA) receptors is vital for the cortical computations underlying cognition and might be disrupted in severe neuropsychiatric illnesses such as schizophrenia. Studies on this topic have been limited to processes in local circuits; however, cognition involves large-scale brain systems with multiple interacting regions. A prominent feature of the human brain's global architecture is the anticorrelation of default-mode vs. task-positive systems. Here, we show that administration of an NMDA glutamate receptor antagonist, ketamine, disrupted the reciprocal relationship between these systems in terms of task-dependent activation and connectivity during performance of delayed working memory. Furthermore, the degree of this disruption predicted task performance and transiently evoked symptoms characteristic of schizophrenia. We offer a parsimonious hypothesis for this disruption via biophysically realistic computational modeling, namely cortical disinhibition. Together, the present findings establish links between glutamate's role in the organization of large-scale anticorrelated neural systems, cognition, and symptoms associated with schizophrenia in humans.
Citations in the library
Cited by 32
- The Predictive Coding Account of Psychosis. Biological Psychiatry May 25, 2018
- Changes in global and thalamic brain connectivity in LSD-induced altered states of consciousness are attributable to the 5-HT2A receptor Elife October 25, 2018
- Reviewing the ketamine model for schizophrenia Journal of Psychopharmacology November 20, 2013
- Linking Microcircuit Dysfunction to Cognitive Impairment: Effects of Disinhibition Associated with Schizophrenia in a Cortical Working Memory Model Cerebral Cortex November 29, 2012
- Glutamate Receptor Antagonists as Fast-Acting Therapeutic Alternatives for the Treatment of Depression: Ketamine and Other Compounds The Annual Review of Pharmacology and Toxicology January 6, 2014
and 27 more in the library
Cites 6
- Subanesthetic Effects of the Noncompetitive NMDA Antagonist, Ketamine, in Humans Archives of General Psychiatry March 1, 1994
- Activation of Glutamatergic Neurotransmission by Ketamine: A Novel Step in the Pathway from NMDA Receptor Blockade to Dopaminergic and Cognitive Disruptions Associated with the Prefrontal Cortex Journal of Neuroscience April 15, 1997
- Reversal of Phencyclidine Effects by a Group II Metabotropic Glutamate Receptor Agonist in Rats Science August 28, 1998
- Modafinil modulation of the default mode network. Psychopharmacology May 2011
- Individual differences in psychotic effects of ketamine are predicted by brain function measured under placebo. Journal of Neuroscience June 1, 2008
and 1 more in the library